Buy Adakveo (crizanlizumab) Online

5.00 out of 5

  • DISEASE INDICATIONS: Sickle Cell Disease
  • MANUFACTURER: Novartis
  • USAGE: Intravenous
  • MEDICINE APPROVED BY:
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
Adakveo, with the generic name crizanlizumab, is a prescription medication used for the prevention of vaso-occlusive crises (VOCs) in individuals with sickle cell disease (SCD).

$1,894.20
Select optionsThis product has multiple variants. The options may be chosen on the product page
Add to wishlist